CATX vs RTX · rev $2.2M vs P/E 36, rev $88.60B
Perspective Therapeutics Inc. (CATX) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
CATX currently screens at market cap $280.6M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the CATX and RTX stock pages for the full models.
Not investment advice.